Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 24
20
Diseases
140
Unique genes
0.341
Avg. similarity score
Hemoglobin m disease
Most-connected disease (12 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Hemoglobin m disease
erythrocytosis, familial, 7
methemoglobinemia, alpha type
Thalassemia
Unstable hemoglobin disease
Alpha thalassemia
Hemoglobin barts fetalis syndrome
Hemoglobin h disease
Methemoglobinemia
Polycythemia vera
Secondary polycythemia
Erythrocytosis
HBA1-related alpha thalassemia spectrum
HBA2-related alpha thalassemia spectrum
Polycythemia
Chloracne
Hematologic disease
Anemia
Bisphosphoglycerate mutase deficiency
methemoglobinemia type 4
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Hemoglobin m disease | 12 | 12 | 3 |
| erythrocytosis, familial, 7 | 10 | 10 | 2 |
| methemoglobinemia, alpha type | 10 | 10 | 2 |
| Thalassemia | 8 | 8 | 5 |
| Unstable hemoglobin disease | 8 | 8 | 3 |
| Alpha thalassemia | 7 | 7 | 3 |
| Hemoglobin barts fetalis syndrome | 7 | 7 | 3 |
| Hemoglobin h disease | 7 | 7 | 3 |
| Methemoglobinemia | 7 | 7 | 6 |
| Polycythemia vera | 6 | 6 | 9 |
| Secondary polycythemia | 6 | 6 | 8 |
| Erythrocytosis | 5 | 5 | 13 |
| HBA1-related alpha thalassemia spectrum | 5 | 5 | 1 |
| HBA2-related alpha thalassemia spectrum | 5 | 5 | 1 |
| Polycythemia | 5 | 5 | 19 |
| Chloracne | 4 | 4 | 33 |
| Hematologic disease | 3 | 3 | 18 |
| Anemia | 2 | 2 | 84 |
| Bisphosphoglycerate mutase deficiency | 2 | 2 | 1 |
| methemoglobinemia type 4 | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| HBA1 | 16 / 20 | Alpha thalassemia, Anemia, Chloracne, Erythrocytosis and 12 more |
| HBA2 | 14 / 20 | Alpha thalassemia, Anemia, Chloracne, Erythrocytosis and 10 more |
| HBB | 10 / 20 | Anemia, Chloracne, Erythrocytosis, Hemoglobin m disease and 6 more |
| JAK2 | 5 / 20 | Anemia, Erythrocytosis, Hematologic disease, Polycythemia and 1 more |
| EPO | 4 / 20 | Anemia, Erythrocytosis, Polycythemia, Secondary polycythemia |
| H2BC4 | 4 / 20 | Anemia, Hematologic disease, Polycythemia, Polycythemia vera |
| ATRX | 3 / 20 | Alpha thalassemia, Hemoglobin barts fetalis syndrome, Hemoglobin h disease |
| BPGM | 3 / 20 | Bisphosphoglycerate mutase deficiency, Erythrocytosis, Secondary polycythemia |
| EGLN1 | 3 / 20 | Erythrocytosis, Polycythemia, Secondary polycythemia |
| EPAS1 | 3 / 20 | Erythrocytosis, Polycythemia, Secondary polycythemia |
| EPOR | 3 / 20 | Anemia, Erythrocytosis, Polycythemia |
| H1-2 | 3 / 20 | Anemia, Hematologic disease, Polycythemia vera |
| HFE | 3 / 20 | Anemia, Hematologic disease, Polycythemia |
| VHL | 3 / 20 | Erythrocytosis, Polycythemia, Secondary polycythemia |
| ACE | 2 / 20 | Anemia, Polycythemia |
| CDK6 | 2 / 20 | Anemia, Chloracne |
| CYB5A | 2 / 20 | Methemoglobinemia, methemoglobinemia type 4 |
| GH1 | 2 / 20 | Anemia, Polycythemia |
| GSTM1 | 2 / 20 | Chloracne, Thalassemia |
| HBD | 2 / 20 | Chloracne, Thalassemia |
| HBS1L | 2 / 20 | Anemia, Hematologic disease |
| HK1 | 2 / 20 | Anemia, Polycythemia |
| HOXD13 | 2 / 20 | Anemia, Hematologic disease |
| IFNA2 | 2 / 20 | Anemia, Polycythemia vera |
| INSL6 | 2 / 20 | Erythrocytosis, Polycythemia |
| MTHFR | 2 / 20 | Anemia, Hematologic disease |
| NUP98 | 2 / 20 | Anemia, Hematologic disease |
| PRKCE | 2 / 20 | Anemia, Polycythemia |
| TMPRSS6 | 2 / 20 | Anemia, Polycythemia |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Pathways in cancer | KEGG | 26 / 533 | 4.2× | 4.23e-10 | 5.24e-8 ✓ sig. |
| Scavenging of heme from plasma | Reactome | 5 / 13 | 33.0× | 2.39e-7 | 1.40e-5 ✓ sig. |
| JAK-STAT signaling pathway | KEGG | 12 / 168 | 6.1× | 5.87e-7 | 3.07e-5 ✓ sig. |
| PI3K-Akt signaling pathway | KEGG | 17 / 361 | 4.0× | 9.83e-7 | 4.80e-5 ✓ sig. |
| Erythrocytes take up oxygen and release carbon dioxide | Reactome | 4 / 9 | 38.1× | 2.13e-6 | 9.27e-5 ✓ sig. |
| African trypanosomiasis | KEGG | 6 / 37 | 13.9× | 3.89e-6 | 1.55e-4 ✓ sig. |
| Hepatocellular carcinoma | KEGG | 11 / 170 | 5.6× | 4.63e-6 | 1.79e-4 ✓ sig. |
| Cytokine-cytokine receptor interaction | KEGG | 14 / 298 | 4.0× | 9.72e-6 | 3.28e-4 ✓ sig. |
| Erythrocytes take up carbon dioxide and release oxygen | Reactome | 4 / 13 | 26.4× | 1.17e-5 | 3.81e-4 ✓ sig. |
| RAF/MAP kinase cascade | Reactome | 9 / 124 | 6.2× | 1.40e-5 | 4.44e-4 ✓ sig. |
| Factors involved in megakaryocyte development and platelet production | Reactome | 8 / 99 | 6.9× | 1.96e-5 | 5.88e-4 ✓ sig. |
| Malaria | KEGG | 6 / 50 | 10.3× | 2.35e-5 | 6.81e-4 ✓ sig. |
| Platinum drug resistance | KEGG | 7 / 75 | 8.0× | 2.58e-5 | 7.34e-4 ✓ sig. |
| Apoptosis | KEGG | 9 / 137 | 5.6× | 3.11e-5 | 8.61e-4 ✓ sig. |
| HIF-1 signaling pathway | KEGG | 8 / 110 | 6.2× | 4.21e-5 | 1.11e-3 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| erythrocyte development | GO:0048821 | 10 / 32 | 41.7× | 2.25e-14 | 1.38e-11 ✓ sig. |
| multicellular organismal-level iron ion homeostasis | GO:0060586 | 8 / 28 | 38.1× | 2.22e-11 | 7.47e-9 ✓ sig. |
| oxygen transport | GO:0015671 | 6 / 17 | 47.1× | 1.84e-9 | 3.83e-7 ✓ sig. |
| response to nutrient levels | GO:0031667 | 9 / 79 | 15.2× | 7.57e-9 | 1.34e-6 ✓ sig. |
| carbon dioxide transport | GO:0015670 | 5 / 13 | 51.3× | 2.69e-8 | 4.02e-6 ✓ sig. |
| cell surface receptor signaling pathway via STAT | GO:0097696 | 6 / 28 | 28.6× | 5.22e-8 | 7.03e-6 ✓ sig. |
| intracellular iron ion homeostasis | GO:0006879 | 8 / 71 | 15.0× | 5.80e-8 | 7.68e-6 ✓ sig. |
| glutathione metabolic process | GO:0006749 | 7 / 49 | 19.1× | 7.53e-8 | 9.49e-6 ✓ sig. |
| positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | GO:0051897 | 12 / 217 | 7.4× | 8.77e-8 | 1.08e-5 ✓ sig. |
| iron ion export across plasma membrane | GO:1903988 | 3 / 3 | 133× | 4.12e-7 | 3.97e-5 ✓ sig. |
| response to hydrogen peroxide | GO:0042542 | 6 / 39 | 20.5× | 4.23e-7 | 4.05e-5 ✓ sig. |
| cellular oxidant detoxification | GO:0098869 | 7 / 66 | 14.2× | 6.14e-7 | 5.56e-5 ✓ sig. |
| embryonic placenta development | GO:0001892 | 5 / 26 | 25.7× | 1.27e-6 | 1.01e-4 ✓ sig. |
| response to isolation stress | GO:0035900 | 3 / 4 | 100× | 1.64e-6 | 1.23e-4 ✓ sig. |
| response to ethanol | GO:0045471 | 8 / 110 | 9.7× | 1.75e-6 | 1.29e-4 ✓ sig. |